Europe Digital Health Market to USD 314.32 Billion by 2034 with a Robust CAGR of 10.27%

The Europe digital health market is experiencing rapid expansion, driven by accelerated digital transformation across national health systems, the European Health Data Space (EHDS) regulatory rollout, demographic pressure from an aging EU population, AI-enabled clinical workflows, and rising consumer adoption of telehealth, wearables, and remote monitoring platforms. The market reached USD 130.37 Billion in 2025 and is projected to reach USD 314.32 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 10.27% during 2026-2034.

Digital health encompasses the use of information and communication technologies (ICTs) to improve disease prevention, diagnosis, treatment, monitoring, and health system management. The market spans telehealth and telemedicine platforms, mobile health (mHealth) applications, electronic health records (EHR/EMR), medical wearables and remote patient monitoring (RPM) devices, healthcare data analytics, and AI-driven diagnostic and decision-support tools.

Rising demand for telemedicine, remote patient monitoring, electronic health records, mobile health applications, and AI-enabled diagnostics is being supported by aging populations, increasing chronic disease burden, and the need to reduce pressure on hospitals and clinics. Strong government focus on healthcare digitization, cross-border health data exchange, and connected care infrastructure is further encouraging investment in digital platforms.

Request a Sample Report for In-Depth Market Insights: https://www.imarcgroup.com/europe-digital-health-market/requestsample

Europe Digital Health Market Summary

• Covers digital health products by type (telehealth, medical wearables, EMR/EHR systems, medical apps, healthcare analytics, others), component (software, hardware, service), and country (Germany, France, United Kingdom, Italy, Spain, others).

• Artificial Intelligence (AI) is one of the most promising and broadly applicable technologies across clinical, operational, and strategic domains. 94% of healthcare providers report that they are already using AI solutions or planning to adopt them, with adoption of AI-powered diagnostic tools projected to approach 80% by 2029.

• In 2025, the EU published the European Health Data Space (EHDS) Regulation, aiming to enhance access, interoperability, and innovative use of electronic health data across member states. The EU AI Act, which entered into force in August 2024 with phased application through 2027, sets requirements for high-risk medical AI systems.

• Cross-border digital health M&A and platform consolidation is intensifying, with vendors racing to establish pan-European presence. In June 2025, Hims & Hers entered the European market via its acquisition of UK-based ZAVA, while in May 2026, Doctolib acquired UK-based Medicus Health to enter the UK digital health market.

PORTER'S FIVE FORCES ANALYSIS - EUROPE DIGITAL HEALTH MARKET

Bargaining Power of Suppliers - Moderate

• Cloud infrastructure providers (AWS, Microsoft Azure, Google Cloud) hold notable influence as adjacent competitors offering scalable healthcare services, though multiple providers compete for health system contracts.

• AI chip manufacturers and semiconductor suppliers exert leverage given the growing demand for AI processing power in healthcare applications, particularly as AI diagnostic tools and clinical decision support systems scale across European hospitals.

• Specialized software developers and data platform vendors retain pricing influence in niche segments such as cybersecurity, genomics analytics, and virtual human twins, where EU dependency on non-EU suppliers remains high.

Bargaining Power of Buyers - Moderate

• National health services and large hospital networks hold significant negotiating power, with public procurement dominating revenue models. Enterprise licensing accounts for 46% of vendor revenue, with institutional procurement shaping pricing dynamics.

• Buyers requiring certified, EHDS-compliant, or AI Act-conforming solutions face narrower supplier choice, shifting some pricing power toward established vendors with regulatory expertise and interoperability credentials.

• Regional health systems benefit from a fragmented vendor landscape, with the top five vendors controlling under 20% of total revenue, enabling competitive bidding on standardized platform deployments.

Threat of New Entrants - Moderate

• High capital intensity and regulatory complexity create substantial barriers for new entrants, with EU AI Act compliance, GDPR requirements, and EHDS interoperability mandates raising entry costs for digital health startups.

• Established players such as Siemens, Koninklijke Philips N.V., and Medtronic benefit from scale, hospital relationships, and regulatory expertise across multiple European markets.

• SME and start-up support programs, combined with EUR 1 Billion Apply AI funding and Horizon Europe virtual human twins initiative (€80 million), are lowering barriers for innovative entrants in specialized segments such as AI diagnostics, digital therapeutics, and remote monitoring.

Threat of Substitutes - Low to Moderate

• Traditional in-person care delivery represents substitute pressure in segments where patient preference or clinician resistance limits digital health adoption, though aging populations and workforce shortages are driving sustained digital transformation.

• Paper-based and legacy IT systems continue to operate in some health systems, though EHDS mandates and national digitalization programs are accelerating replacement with cloud-based EHR and connected care platforms.

• Advanced genomics and biological sensor technologies pose modest substitution pressure in specialized diagnostic segments, though software platforms remain essential for data integration and clinical workflow.

Competitive Rivalry - High

• Competitive intensity is high among major vendors including Siemens, Koninklijke Philips N.V., Medtronic, Oracle, and Epic Systems Corporation, competing on platform scale, interoperability, AI integration, and regulatory compliance.

• Decarbonization and sustainability capabilities are emerging as differentiators, alongside AI-enabled diagnostic accuracy and EHDS-aligned data exchange.

• Regional specialists including Doctolib, Doccla, and Ada Health anchor country-specific layers, leveraging local reimbursement frameworks, while M&A activity intensifies rivalry among platform consolidators seeking pan-European scale.

MARKET GROWTH DRIVERS

Aging Population and Rising Chronic Disease Burden

Europe holds one of the world's oldest demographic profiles, with approximately one-fifth of the EU population aged 65 or older as of early 2025. Remote patient monitoring, telehealth consultations, and digital therapeutics enable proactive intervention and continuous care for chronic-disease patients, reducing acute episodes and hospitalizations. Chronic disease management remains a cornerstone of national e-health roadmaps, driving sustained demand for RPM platforms, wearable sensors, and AI-enabled predictive analytics.

Government Support and EHDS Regulatory Advancement

European governments are providing significant support through funding programs, tax incentives, and regulatory frameworks encouraging investment in healthcare digitization. Germany's DiGA framework allows certified digital health apps to be prescribed and reimbursed under statutory healthcare, with 64 DiGA-approved applications generating over EUR 125 million in reimbursable revenue. France's PECAN fast-track reimburses evidence-based apps within 60 days. Italy's EUR 15.6 Billion healthcare mission covers community care, telemedicine, and digitalization under the National Recovery and Resilience Plan (2021-2026). The EHDS Regulation, published in 2025, establishes standardized EHR specifications enabling citizens to access health information across member states.

AI and Cloud Integration in Clinical Workflows

AI applications span medical imaging, pathology, clinical decision support, and population health analytics. In October 2025, the European Commission launched the EUR 1 Billion Apply AI strategy funding AI-powered screening centers for early disease detection. Siemens, Koninklijke Philips N.V., and Oracle are embedding AI diagnostic modules, predictive analytics, and population health tools into EHR and imaging platforms, accelerating multi-country deployments. AI is not only one of the most promising technologies but also one of the most broadly applicable, with 94% of healthcare providers already using AI solutions or planning to adopt them.

Healthcare Workforce Constraints Driving Automation

A 2025 survey of 442 healthcare executives across 13 European countries found severe staffing shortages, with 90% of German hospitals affected. Digital scheduling, RPM, virtual care, and AI-assisted documentation enable redistribution of clinical workload across teams, supporting service continuity amid demographic pressure. Clinical decision support systems alone could deliver up to EUR 252 billion in net cost avoidance over a ten-year period, equivalent to around 1% of total EU healthcare expenditure.

Browse Full Report with TOC & List of Figures for In-Depth Market Insights: https://www.imarcgroup.com/europe-digital-health-market

EUROPE DIGITAL HEALTH MARKET SEGMENTATION

Component Insights:

• Software
• Hardware
• Service

Type Insights:

• Telehealth
• Medical Wearables
• EMR/EHR Systems
• Medical Apps
• Healthcare Analytics
• Others

Country Insights:

• Germany
• France
• United Kingdom
• Italy
• Spain
• Others

COMPETITIVE LANDSCAPE

The Europe digital health market features a structurally fragmented competitive landscape, with the top five vendors collectively controlling under 20% of total revenue. Leading integrated players-Siemens, Koninklijke Philips N.V., Medtronic, Oracle, and Epic Systems Corporation-differentiate through platform scale, AI integration, regulatory expertise, and interoperability credentials.

Siemens (including Siemens Healthineers) anchors its enterprise software portfolio with the teamplay Digital Health Platform and AI-Rad Companion clinical decision support suite. In August 2025, Siemens Healthineers and Sony Healthcare Solutions Europe announced a strategic global collaboration integrating Siemens' ARTIS angiography systems with Sony's NUCLeUS audio-visual management platform.

Koninklijke Philips N.V. maintains a strong Connected Care segment encompassing telehealth, RPM, sleep and respiratory care, and enterprise informatics solutions. In May 2026, a Philips-included consortium with Cuviva and Vingmed was selected to support Region Stockholm's hospital-at-home initiative, enabling advanced remote monitoring for up to 15,000 patients annually.

Regional specialists including Doctolib, Doccla, and Ada Health anchor country-specific layers, with Doctolib leveraging local reimbursement frameworks. M&A activity is intensifying, exemplified by Hims & Hers' June 2025 acquisition of ZAVA and Doctolib's May 2026 acquisition of UK-based Medicus Health.

Cloud infrastructure providers (AWS, Microsoft Azure, Google Cloud) are emerging as adjacent competitors, offering scalable healthcare services.

Key players include:
• Siemens
• Koninklijke Philips N.V.
• Medtronic
• Oracle
• Epic Systems Corporation

REGIONAL ANALYSIS

United Kingdom: The United Kingdom leads Europe's digital health market with a 26.0% share in 2025, anchored by the NHS Long Term Plan digital transformation funding, sustained UK health-tech venture capital activity, and the concentration of innovation hubs across London, Cambridge, and Oxford. London-based Doccla raised GBP 35 Million in September 2024 to scale RPM across the UK and Europe. The United Kingdom recorded the highest growth outlook among major markets.

Germany: Germany is the second-largest market at 21.8% in 2025, anchored by plans to invest around EUR 2 billion in a national healthcare cybersecurity program running until 2029. The country's DiGA reimbursement framework has generated over EUR 125 million in reimbursable revenue, with 64 DiGA-approved applications. Electronic patient records became mandatory on an opt-out basis in January 2025, creating a nationwide data backbone that accelerates vendor scale-up. German hospitals have received EUR 300 million in government allocation for EHR and cybersecurity upgrades.

France: France accounts for 18.6% of the market, leading telehealth adoption with the PECAN fast-track reimbursement framework for evidence-based apps within 60 days. The country's national e-prescription rollout and Doctolib's platform expansion have accelerated virtual consultation adoption. Doctolib entered the UK market in May 2026 through its acquisition of UK-based Medicus Health.

Italy: Italy holds a 13.7% share, supported by its EUR 15.62 billion community-care digitalization plan targeting 1,350 local health hubs. The National Recovery and Resilience Plan (2021-2026) covers telemedicine, digitalization, and community care. Regional skill gaps slow execution, though EU recovery fund-supported initiatives are driving sustained growth.

Spain: Spain accounts for 10.9% of the market, with growing telehealth adoption across regions and public-private partnerships strengthening regional health systems. The country's focus on renewable energy infrastructure and green urbanization is not directly relevant to digital health, though government-backed digital health initiatives continue to expand.

Others: The remaining 9.0% of the market includes the Netherlands with near-universal electronic health record adoption and Nordic states advancing cross-border health data exchange. Eastern European and Nordic markets present substantial growth headroom as EU recovery and structural funds accelerate national digital health investments.

RECENT INDUSTRY DEVELOPMENTS

October 2025: The European Commission launched the EUR 1 Billion Apply AI strategy funding AI-powered screening centers for early disease detection, accelerating deployment of AI diagnostic tools across European health systems.

November 2025: The European Health and Digital Executive Agency (HaDEA) signed new EU4Health contracts to strengthen the European Health Data Space (EHDS) and help stakeholders comply with secondary-use data requirements, establishing standardized EHR specifications across member states.

June 2025: Hims & Hers entered the European market by acquiring UK-based digital health platform ZAVA, accelerating its move into the UK, Germany, France, and Ireland across dermatology, mental health, and weight loss.

May 2026: A Koninklijke Philips N.V.-included consortium with Cuviva and Vingmed was selected to support Region Stockholm's hospital-at-home initiative, enabling advanced remote monitoring for up to 15,000 patients annually.

May 2026: Doctolib acquired UK-based Medicus Health to enter the UK digital health market, signaling intensifying cross-border M&A as platform consolidators race for pan-European scale.

February 2025: The European mHealth Innovation and Knowledge Hub, the World Health Organization's first reference centre for mobile health innovation in Europe, was launched in Geneva, chaired jointly by WHO, the International Telecommunication Union, and the Andalusian Ministry of Health.

August 2024: The EU AI Act entered into force with phased application through 2027, setting requirements for high-risk medical AI systems including explainability, transparency, and algorithmic safety standards.

September 2024: London-based Doccla raised GBP 35 Million to scale remote patient monitoring across the UK and Europe, enabling 24/7 patient tracking and reducing emergency admissions.

April 2024: OMRON Healthcare Co., Ltd. acquired Luscii Healthtech, whose multi-condition RPM software is deployed in 70% of the Netherlands' hospitals, expanding connected care capabilities across European health systems.

Note: If you need any specific information that is not covered currently within the scope of the report, we will provide the same as a part of customization.

Speak to an analyst: https://www.imarcgroup.com/request?type=report&id=10917&flag=E

Browse Other Trending Reports by IMARC Group
• Europe Biosimilar Market: https://www.imarcgroup.com/europe-biosimilar-market
• Europe Feed Vitamins Market: https://www.imarcgroup.com/europe-feed-vitamins-market
• Europe Generic Drug Market: https://www.imarcgroup.com/europe-generic-drug-market
• Europe In Vitro Diagnostics Market: https://www.imarcgroup.com/europe-in-vitro-diagnostics-market

Contact Us

IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201-971-6302

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.